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⚫Elective surgery after stroke: How long we have to wait?
History of cerebral autoregulation Curve  
⚫Fog in 1930 first observed cerebral 
autoregulation(constriction and dilatation)of blood 
arteries for varying degrees of blood pressure on a 
cat’s pia mater through a cranial window.
Ref:  1.Fog M: cerebral circulation. The reaction of of the pial arteries to 
fall in blood pressure. Arch Neurol Psych 1937: 37: 351-64
2. Fog M:  Cerebral circulation II.  The reaction of the pial arteries to 
increase in blood  pressure. Arch  Neurol Psych 1939; 41;260-68
History of cerebral autoregulation Curve  
Journey from 1959 to 2020: from Static to 
dynamic
⚫Lassen in in 1959 first described  the lower limit of  
autoregulation.
⚫His concept was based on over 200 clinical studies 
based on
a) assessing CBF flow using inert gas technique 
b) indicator dilution method
Studies of controlled hypotension in humans
Fick principle and Kety-Schmidt technique
Ref: Lassen NA: Cerebral blood flow and oxygen consumption in man. 
Physiol rev 1959; 39:183-89
Lassen 1959 concept of 
autoregulation
Inert gas technique: Measures arteriovenous difference
Indicator dilution method: Measures the venous 
dilution of an arterially injected indicator
Lassen 1959 concept of 
autoregulation
Fick principle:
Blood flow to the  brain= Amount of the substance 
injected X arterial and  venous difference of the 
substance
Kety-Schmidt technique: Quantitative measurement 
of arterial and venous blood flow from washout curves 
of the diffusible tracer material
History of cerebral 
autoregulation curve
Upper limit of the cerebral was described in 
1971.
Ref: 1. Europ Neurol 1971; 6; 6-10
2. Stroke 1973; 4: 139-47
History  of cerebral Autoregulation curve 







Ref: Journal of Cerebral Blood Flow & Metabolism 2008 
: 28, 1071–1085
Cerebral Autoregulation Curve 
from 1959  to 2020?
Do we need to revise the lower 
limit of autoregulation?
Do we need to revise the lower 
limit of autoregulation?
Drummond JC:Correspondence to the editor
The Lower Limit of Autoregulation:Time to 
revise our Thinking?
Ref: Anesthesiology 1997;86:1431-33 

Cerebral autoregulation curve Image from Lemkuil BP, Drummond JC, Patel PM. 
Central nervous system physiology: Cerebrovascular. In Hummings HC, Egan TD, eds. 
Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. 
Philadelphia, PA: Elsevier; 2019:174-192, Fig. 9.7. 
Copyright  2019 by Elsevier, Inc.
Lower limit of Cerebral autoregulation
Lower Limit of cerebral Autoregulation= 70 
mm Hg
Ref:  1. Anesthesia for Neurosurgery, Smith's Anesthesia for Infants and 
Children 2017; 744-72
2. Miller’s anesthesia 2020, 9th edition
Cerebral Autoregulation curve 
Anesthesia for Neurosurgery, Smith's Anesthesia for Infants and Children 
2017; 744-72

Dynamic Cerebral Autoregulation : Miller’s anesthesia 2020. 
9th edition
Effect of PaCO2 on cerebral autoregulation: 
Miller’s Anesthesia 2020, 9th edition
Cerebral autoregulation curve in acute intracranial event
Ref: Miller’s Anesthesia 2020, 9th edition
Pathophysiology of EBI
Early brain injury (EBI) formerly known as primary 
brain injury.
Loss of cerebral autoregulation
Loss of blood brain integrity
EBI: Past historical concept of 
Systemic Hypertension
CPP = MAP- ICP
Systemic hypertension secondary to Cushing's 
reflex.
EBI: Hypertension current concepts
⚫Following EBI, massive sympathetic discharge and 
catecholamine release resulting in hypertension and 
tachycardia
⚫Cytokine release can result in leaky capillaries: 
pulmonary edema
⚫ Lower BP: cerebral ischemia, at higher MAP, 
cerebral edema
Ref:   1 Intensive care 2016; 4: 29
2. Neurosurg Focus 2019; 45;5
3.  J Neurosurg Anesthesiol 2017; 29:382-87
EBI: Pathophysiology
⚫Catecholamine surge: EKG changes, wall motion 
abnormalities on TEE: Takotsubo cardiomyopathy(1)
⚫Cytokine release: leaky capillaries, neurogenic 
pulmonary edema.(2)
References:
1. Krishnamoorthy V, Mackensen GB, Gibbons EF, Vavilala MS. Cardiac 
Dysfunction After Neurologic Injury: What Do We Know and Where Are 
We Going?. Chest 2016;149:1325‐31
2. Bust K, Bleck T: Neurogenic pulmonary edema. Crit Care Med 2015:43; 
1710-15
TBI :?Beta Blockers
TBI with beta blockers: Systematic review and meta-
analysis.(9 studies n= 8245)
Results: Low quality of evidence of reduction in hospital 
mortality (OR: 0.39, CI 95%)
Long term functional outcomes were not measured in 
these studies.
Ref: Alai AS et al: Beta-Blockers and Traumatic Brain Injury: A Systematic 
Review and Meta-Analysis. Ann Surg 2017; 266; 952-61

aSAH and post event Beta blockade
A meta-analysis and systematic review reported in  2020
16 studies, 4 RCT’s 12 prospective observational
n=6702 
Results:  In house mortality benefit (OR 0.50 CI 95%), 
Limitations:  Heterogeneity
Ref:Ramesh, A.V., Banks, C.F.K., Mounstephen, P.E. et al. Beta-Blockade 
in Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and 
Meta-Analysis. Neurocrit Care 2020. https://doi.org/10.1007/s12028-020-00915-5
Reference point to measure ABP 
in neurosurgical patients
⚫Past: External auditory meatus
⚫Current: Highest point of the head
Ref: Drummond:  ASA refresher course lecture, 
Boston 2018 
EBI:hypertension management in neurosurgical 
Patients: What drugs?
⚫Vasodilator drugs: Hydralazine, nitroprusside and 
nitroglycerine should not be used.
⚫Calcium channel blockers: Clevidipine, nicardipine  
are preferred
⚫Beta blockers can be used except in DBS macro 
electrode implantation
References:
1. Neurocrit Care 2011;15:211–240
2. Stroke 2012;43:1711–37
Target BP in neurosurgical patients: 






Target BP in TBI as per BTF 
guidelines
⚫Brain trauma foundation(BTF) guidelines developed 
by the  American congress of Neurosurgeons for 
management of Traumatic Brain Injury(TBI)
⚫Third edition in 2007
⚫Fourth edition in 2017 (called 2016 guidelines)
2016 BTF guidelines: What is new?
Redefining hypotension in  TBI
⚫BTF guidelines( third edition in 2007): Defined 
hypotension as systolic BP less than 90 mmHg.
⚫BTF guidelines( Fourth edition 2016 guidelines): 
defined hypotension as systolic BP less than 110 mm 
Hg
Ref:  1 BTF guidelines 2016: 4th edition
2. Berry C, Ley EJ, Bukur M, et al. Redefining hypotension in traumatic brain 
injury. Injury. Nov 2012;43:1833-37
3  Brenner M, Stein DM, Hu PF, Aarabi B, Sheth K, Scalea TM. Traditional 
systolic blood pressure targets underestimate hypotension-induced secondary 
brain injury. J Trauma Acute Care Surg. May 2012;72: 1135-39
Redefining hypotension……...
BTF analysed the data from 
⚫Two class II retrospective studies(n=22594)( ref 1, 2, 
3)
⚫ 16 Class III retrospective and prospective 
observational data(n=2444)( ref 3)
Ref 1.Berry C, Ley EJ, Bukur M, et al. Redefining hypotension in traumatic 
brain injury. Injury. Nov 2012;43:1833-37.
2. J Trauma Acute Care Surg 2012;72:1135-1139
3. Brain Trauma Foundation Guidelines 2016, 4th edition
TBI: Target pressure
Target cerebral perfusion (CPP)
Third edition: 50- 70 mm Hg (BTF 2007)
Fourth edition 60-70 mm Hg (BTF 2016)
Ref: BTF guidelines 2016:4th edition
Redefining CPP……..
BTF analysed the data from…….
1 RCT
15 Retrospective data
( total n= 4619)
Ref Brain Trauma Foundation Guidelines 2016, 4th 
edition
.
A patient with severe head injury  with GCS of 4 
presents for  emergency evacuation of an 
hematoma. What is your target MAP?
Target MAP during Acute TBI management
CPP = MAP- ICP
MAP = CPP + ICP
MAP = 60+ ( 20 or 25)= 80-85
MAP = 70+ ( 20 or 25)= 90-95
TBI: Why narrow range  MAP?
⚫Loss of cerebral autoregulation
⚫Loss of blood-brain integrity
⚫CBF depends on MAP
⚫Hypotension results in hypoperfusion
⚫Hypertension results in hyperperfusion and cerebral 
edema
AIS: Target BP prior to EVT
⚫Target  BP prior to EVT(endovascular 
thrombectomy)
140-180 mmHg systolic
Why higher BP in AIS prior to EVT? :for collateral 
blood flow through circle of Willis
Ref:  J Neurosurg Anesthesiol 2014;26:95-108
Target BP after EVT in AIS
⚫ A  retrospective analysis of data from 3 RCT’s(comparing 
GA vs MAC for EVT) reported in 2020;
⚫ n= 365 (SIESTA, ANSTROKE, GOLIATH)
⚫ MAP less than 70 over 10 min and MAP greater than 90 
over 45 min is associated with poor functional outcome at 
90 days(mRankin score).
Ref: JAMA Neurol 2020; 77:622–631
Target BP in Spontaneous 
Intracerebral hemorrhage (sICH)
INTERACT 2 trial: Compared systolic BP less 140 mm 
Hg(intensive group) Vs systolic BP less than 180 mm Hg 
⚫n= 2794 (randomised within 6 hours of sICH)
⚫Outcome measures death and disability rate  on 
mRankin score at 90 days
⚫Results: Mortality 11.9 % intensive group vs 12.0% 
and  non fatal disability rate 23.3% vs 23.6%
Ref:N Engl J Med 2013; 368:2355-2365
Target BP in sICH
ATTACH 2 trial
Compared 110-139 mmHg systolic to 140-179 mm Hg 
systolic within 4.5 hours of ICH symptoms (mean 128 
mmHg  Vs 160 Hg)
n= 1000
Primary outcome measures: death and disability rate at 
90 days did not differ between the two groups.
Ref: N Engl J Med 2013; 368:2355-2365
Target BP in ICH
Analysis of Data from ATTACH 2 trial:
Elevation of creatinine within 7 days(1)
Neurological deterioration within 24 hours(2)
Adverse cardiac events within 7 days (2)
Adverse events were higher in intensive group
References:
1. N Engl J Med 2016; 375:1033- 1043
2. Stroke 2018;49:1412–1418
Target BP for aSAH prior to 
securing aneurysm
⚫Prior to 2011 : Systolic BP 180 mm Hg prior to coiling or 
clipping
⚫2011: 160  mm Hg as systolic as per neurocritical care  
consensus statement (1)
⚫2012: Above statement endorsed by ASA of the AHA(2)
Currently based on results of INTERACT 2(3) and ATTACH 
2 trials: 140 mm Hg(4)
References: 
1,Neurocrit Care. 2011;15:211–240. 
2.Stroke 2012;43:1711–1737
3.N Engl J Med 2013; 368:2355-2365
4. N Engl J Med 2016; 375:1033- 1043
Target BP for temporary clipping
⚫Maintain the BP or elevate above the 
MAP.
⚫Maintain burst suppression on EEG.
Aneurysm clipping Target BP for 
induced hypotension
⚫BP of 50 mm Hg: achieved by 
clevidipine
⚫Adenosine 0.3-0.4 mg/kg
aSAH: Target BP for DCI after securing 
aneurysm
HHH therapy is part of the history now!
Hypervolemia and hemodilution not used now.
What about induced hypertension? : Its role is 
controversial
Induced hypertension to prevent DCI 
after secring aneurysm in aSAH?
RCT( n=240) was prematurely terminated after 
recruiting 42 patients : after observing no benefit
Ref 1: Stroke 2018;49:76–83
Induced hypertension to prevent DCI 
after secring aneurysm in aSAH?
Retrospective data analysis reported in 2018 
3 academic centers from Netherlands, 2006-2015)
n= 1647
479 showed DCI
300 showed cerebral infarction on CT scan 
.
⚫201 were treated with induced hypertension, 99 were 
not treated with induced hypertension
⚫With induced hypertension 41/201(20%) compared  
33/99(30%) without induced hypertension 
developed cerebral infarct.
Ref: Stroke 2018; 49:2630-2636
Target BP for Deep Brain Stimulation
⚫Less than 140 mm Hg , not below 120 mm Hg for 
macro/microelectrode implantation.  
⚫BP above 14o mm Hg is associated with intracerebral 
hemorrhage and worse neurological outcome as per 
case series.
⚫Hemodynamic changes(hypertension/hypotension 
can occur during Macro/micro electrode implantation 
during DBS
Ref:Front Neurosci. 2017; 11: 477
Target BP: Summary
.
Neurosurgical condition Target BP/CPP in mm Hg
TBI CPP: 60-70
Avoid systolic BP below 110 
AIS prior to EVT 140-180 systolic





⚫Normocarbia, Paco2 35-40 mm Hg is the goal
⚫Hypercarbia increases cerebral blood flow and 
abolishes cerebral autoregulation curve
⚫Hypocarbia preserves the autoregulation curve with 
decrease in CBF.
Ref: Miller’s Anesthesia 9th edition ; 2020
PaCO2 management In TBI
⚫Cerebral blood flow decreases  to 50% of the normal 
at the end of 4 hours and reaches to 80% of the 
normal at the end 24-72 hours based on severity of 
the TBI
⚫Hyperventilation contraindicated for the first 24 
hours after TBI.
Ref: 2016 BTF guidelines 4th edition
PaCO2 management: Why frequent 
measurement of arterial PaCO2 is essential?
⚫Patient with acute intracranial event: catecholamine 
surge
⚫Decreases pulmonary capillary blood flow
⚫Increases dead space ventilation
⚫Increases PCo2- End- tidal Co2 differences
⚫Hourly estimation of PaCo2 to identify PaCo2-End 
Tidal CO2 gradient.
.
TIVA vs Volatile anesthetics 
for Neuroanesthesia 
Which is the best technique?
Anesthesia technique: TIVA vs 
Volatile anesthetic agents
⚫A meta-analysis of  14 RCT’s 
⚫n= 1891
⚫ TIVA: Propofol/fentanyl and  Propofol/remifentanil 
⚫ Volatile anesthetic agents: Isoflurane/sevoflurane 
in air/oxygen mixture 
⚫ASA 1-3
⚫Patients had no or minimal midline shift on CT scan
Ref: Can J Anaesth 2014; 61:347-56
Results in TIVA group compared volatile agent 
group
1. ICP= -5.2 mm/Hg less( 95% confidence interval -
6.81 to -3.6 mm HG)
2. CPP was +15.3 mm Hg ( 95% confidence interval 
12.2 to 20.46 mm Hg)
3. Limitations: Outcome measures were not studied 
in these trials of this meta-analysis.
Ref: Can J Anaesth 2014; 61:347-56
TIVA or  Volatile agents?
A recent study reported in 2019
⚫n= 90 patients with TBI 
⚫45 received propofol based TIVA 100-150 
mcg/kg/min
⚫45 received Isoflurane 1 MAC or less 
⚫Results: ICP was lower in TIVA group and brain 
relaxation at dural opening and closure was better 
with TIVA group
Ref:Eur J Trauma Emerg Surg 2019 https://doi.org/10.1007/s00068-019-
01249-4
Neurological recovery: TIVA vs 
Volatile agents?
A Cochrane review in 2016 (15 RCTs, n=1833) reported that 
neurological recovery is similar in both TIVA volatile 
anesthetic agent based technique in patients undergoing 
brain tumor surgery.
Ref: Cochrane Database Syst Rev 2016;9:CD010467
IV vs inhalational technique?
TIVA alone  or with lower concentration of volatile 
anesthetic most commonly used popular technique in 
neuroanesthesia.
References;
1. Miller's anesthesia 9th edition 2020
2. Uptodate 2020
3. Pasternak JJ: Neuroanesthesiology Update. J Neurosurg Anesthesia 
2019; 2; 178-98
Why TIVA is preferred in 
Neuroanesthesia?
⚫Propofol based TIVA maintains cerebral 
autoregulation curve and decreases the ICP.
⚫Volatile anesthetic agents suppress the cerebral 
autoregulation.
Ref:
1. Armstead WM: Cerebral autoregulation and dysregulation. 
Anesthesiol Clin. 2016 34: 465–477
2. Miller’s Anesthesia 2020; 9th edition
Effect on cerebral autoregulation
Anesthesiology 1995;83, 66-76 ( n=42, TCD)
Ref Sharma D: ASA refresher course lecture 2019
Cerebral blood flow: TIVA vs 
Sevoflurane 
⚫A Study from Finland: reported in 2003
⚫ASA grade 1 healthy male volunteers (8)
Ref: Anesthesiology 2003; 99:603-613
⚫ Induced with sevoflurane 8% and intubated with 
rocuronium 0.6mg/kg body weight 
⚫Maintained with sevoflurane 
⚫Then added 70%N20  after 50 min
⚫ TCI of propofol and then added 70% N20 after 50 
min 
Ref: Anesthesiology 2003; 99:603-613
⚫ Anesthesia depth BIS 40 
⚫ (Average sevo 1.5% end tidal (range 1.1%-1.9%, 
propofol tcI 4ng/ml)
⚫ Cerebral blood was observed on PET scan 
Ref: Anesthesiology 2003; 99:603-613

Volatile anesthetic agents concentration greater 
than 1 MAC should be avoided.
Ref: Miller’s 9th edition, 2020
Which volatile anesthetic agent?
Vasodilatory effect: desflurane > Isoflurane > 
sevoflurane
(under 1 MAC clinically not significant)
Miller’s Anesthesia 9th edition; 2020
IV vs inhalational technique?: Current concept
⚫ In patients with elevated ICP: Volatile anesthetic 
agent concentration should be limited to 0.5 MAC.
⚫ In acute  expanding intracranial events such as TBI/ 
aSAH, persistently elevated ICP in brain tumors:  
volatile anesthetic agents should be avoided 
altogether at least until the dura is opened.
Ref: 
1. Miller’s Anesthesia 2020; 9th edition
2. Armstead WM: Cerebral autoregulation and dysregulation. 
Anesthesiol Clin. 2016 Sep; 34: 465–477
Dexmedetomidine and 
remifentanil
⚫Commonly used adjuncts with propofol when EEG, 
MEP and SSEP monitoring is used.
⚫Reduces the dosage of propofol and enable to 
monitor EEG without causing burst suppression
Dexmedetomidine
⚫Widely used in neuroanesthesia
⚫Provides analgesia 
⚫Reduces emergence delirium
⚫Reduces dosage of propofol
⚫Doesn’t affect EEG monitoring significantly
⚫ Infusion dosage should be limited to 0.5 mcg/kg/hr 
when MEP monitoring used.
⚫Part of the regimen for awake-asleep-awake 
craniotomies and DBS.
Ref: 1 J Neurosurg Anesthesiol 2019; 31: 366-77
2. J Clin Anesth. 2019; 54:114-125. 
Remifentanil in 
Neuroanesthesia
1. Reduces sympathetic response to intubation and 
insertion of Mayfield pins
2. NeuroMorfeo Trial: Reduced the urinary 
catecholamine levels ( ref 1)
3. Reduction in in-house mortality rate in patients 
with clipping of ICA aneurysms when remifentanil 
was used as per  a retrospective Japanese database 
analysis ( ref 2)
References: 
1. Eur J Anaesthesiol. 2012; 29:371-9
2. J Neurosurg Anesthesiol. 2014;26:291–298
Fluid Management 
in Neurosurgery
Fluid management in 
Neurosurgery
⚫NS osmolality closer to plasma
⚫LR is slightly hypotonic.
⚫ Chloride rich solutions that contribute toward 
hyperchloremic acidosis and impaired renal blood 
flow.(Ref 1,2,3)
⚫As transfusion of NS associated with  metabolic  acidosis 
and  renal dysfunction LR or plasmalyte  are  commonly 
used in neurosurgery.(Ref 1, 2, 3)
Ref: 1. Miller’s 9 the edition, 2020
2. Pasternak JJ: Neuroanesthesiology Update. J Neurosurg Anesthesia 2019; 
2; 178-98
3. Dabrowski W., Wise R., Malbrain M.L.N.G. Fluid Management in 
Neurosurgical Patients.Textbook of Neuroanesthesia and Neurocritical 
Care 2019; 373-382
Fluid management in 
Neurosurgery
⚫Replace half of the urine as fluids  when mannitol is used.
⚫Goal is to maintain Euvolemia.
⚫If large amount of fluid transfusion is needed ( more than 
two liters alternate NS with LR.
⚫Fluid warmer is not needed for a routine craniotomy for 
tumor surgery, as large volume of fluids are not needed in 
routine craniotomy for tumor surgery
Ref: Miller’s Anesthesia  2020, 9th edition.
Albumin  in neurosurgical patients : TBI
Subset analysis of SAFE  trial in  severe TBI (GCS 3-
4)patients in 2009 reported higher morality with 4% 
albumin at 30 days.
Ref: N Engl J Med 2007; 357: pp. 874-884
? Albumin in TBI
Limitation for this conclusion of SAFE trial:
1. Not randomized to include TBI (1)
2. 4% albumin was hypoosmolar (osm 274 
mOsmol/L)(2)
References:
1. Anesth Analg 2011; 113: pp. 426-427
2. Curr Opin Anaesthesiol 2012; 25: pp. 563-565
? Albumin in TBI
A single center  retrospective analysis (n=93) from 
Sweden reported  a lower 28 day  and 18 month 
mortality in severe TBI patients when albumin was used 
with zero or negative fluid balance in TBI patients. 
Ref: Acta Anaesthesiol Scand 2008; 53: pp. 18-25
Albumin in aSAH
⚫25% albumin was found to be beneficial in aSAH as 
per ALISAH pilot trial(n=47)(1)
⚫Lower incidence of TCD vasospasm, DCI and 
cerebral infarction at 90 days.(2)
References:
1. Suarez JI, Martin RH, Calvillo E, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) 
multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 
2012;43(3):683‐690
1. Suarez J.I., Martin R.H., Calvillo E., Bershad E.M., and Venkatasubba Rao C.P.: Effect of 
human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid 
hemorrhage: the ALISAH study. Acta Neurochir Suppl 2015; 120: pp. 287-290
Albumin in AIS: ALIAS phase 3 trial
Age 18-82,  NIHSS score <or = 6 
n=830
NS vs 
25%albumin ( 2gm/Kg) infused over 2 hours within 5 hours of stroke 
onset.
Results: Symptomatic ICH ( at 24 hours) and CHF/pulmonary 
edema was more common with albumin group.
Overall neurological outcome was similar in both groups.
Ref: PLoS One 2015; 10: e0131390
Hyperosmolar therapy:
Mannitol Vs Hypertonic saline
Which is better?
Hyperosmolar therapy In TBI: 
Mannitol Vs hypertonic saline 
⚫HTS decreases the ICP better than Mannitol without 
short term outcome difference
⚫2007 BTF guidelines: HTS was preferred over 
Mannitol in TBI patients.
⚫2016 BTF guidelines:Either mannitol or HTS is 
acceptable.
HTS vs Mannitol in TBI
⚫A meta-analysis in 2019 (12 RCT’s  n= 464) found  
decrease in ICP  was better with HTS at 30-120 min 
interval.
⚫No outcome difference at discharge
⚫Long term outcome was not studied in the trials of 
this meta-analysis.
Ref : J Neurosurg Anesthesiol 2019; 00:000–000 DOI; DOI: 
10.1097/ANA.0000000000000644
HTS vs Mannitol in TBI
⚫A Cochrane review in 2020( n=287, 6 RCT’s) comparing 
Mannitol vs HTS
⚫91% of these patients had GCS of less than 8 (severe TBI)
⚫3 trials reported outcome with regard to hospital 
discharge, out of which 2 reported in house mortality. 
Conclusion: No difference in outcome
Limitations: Heterogeneity of methodology of the trials.
Ref: Cochrane Database of Systematic Reviews 2020; CD010904.
Mannitol Vs HTS for brain tumor 
surgery
⚫A meta-analysis in 2015 of 7 RCT’s reported 
better brain relaxation with HTS compared to 
mannitol.
⚫Limitation: Heterogeneity of the trials, other 
factors were not standardized.
Outcome measures were not studied.
Ref: PLoS One 2015; 10: e0117314. PMID:25635862
Mannitol
⚫Mannitol 20%
⚫Dose: 0.25 gm/kg  to 1 gm/kg
⚫1Gm/ Kg is the optimum dose
Ref: Miller’s 9th edition 2020
Uptodate 2020
J Neurosurg Anesthesiol 2020;32:307–314
Mannitol In neurosurgery
FDA has also approved mannitol 25% in 
neuroanesthesia.
Rate of administration 20% or 25%: over 30-60 min.
Ref:  FDA 2019 recommendation of Mannitol.
Mannitol in Brain tumor surgery
Optimum dose of mannitol is 1 gm/kg( Ref 1,2, 3).
Tumor size and peritumoral edema are primary   
determinants of mannitol dose rather than midline shift 
(Ref 2)
Ref:
1. Miller’s Anesthesia, 9th edition, 2020
2. J Neurosurg Anesthesiol 2020;32:307–314
3. J Neurosurg 2017; 126:1747-2058
Mannitol in Brain tumor surgery
⚫ Higher doses of mannitol produces better brain relaxation.
⚫ Higher doses of mannitol is associated with electrolyte 
abnormalities: Hyponatremia, hyperkalemia and increased 
serum osmolality.
⚫ Higher dose of mannitol may cause postoperative cerebral 
edema
Ref :  
1. Uptodate 2020
2. J Neurosurg Anesthesiol 2020;32:307–314





⚫TBI: early benefit for 1 week to prevent seizures, no 
long term benefit.
Ref; BTF guidelines, 4th, edition 2016
Anti- seizure prophylaxis
TBI
⚫A recently published meta-analysis and systematic 
review in 2019
⚫3 RCT’s(n= 750) and 6 observational studies (n=3362)
Results: Benefit was limited early seizure prevention 
only.
Ref: World Neurosurg 2019;122:433-440
Prophylactic Anti-seizure 
medications: Brain tumor surgery
A meta-analysis  reported  in 2019
⚫2 RCT’s and 4 retrospective analysis.
⚫454 received anti-seizure medications 
⚫333 did not receive anti-seizure medications, or placebo 
in RCT
Results : No benefit from anti-seizure medication
Ref: Journal of Neurology, Neurosurgery & Psychiatry 2019;90:599-607.
Prophylactic Anti-seizure 
medications: Brain tumor surgery
⚫A 2020 Cochrane review also did not find the 
benefit of anti-seizure prophylaxis( 10 trials, n= 
1815)
Ref: Cochrane Database of Systematic Reviews 2020; CD007286.
Antiseizure prophylaxis for aSAH?
A retrospective data analysis (n-363,  43% received anti-
seizure prophylaxis): No benefit
Ref: Stroke 2016; 47:1754-60
Anti-seizure prophylaxis in 
sICH
⚫Not recommended as per 2015 AHA clinical 
guidelines(Class 3 Level B evidence)
⚫Not recommended as per  2014 European Stroke 
Association guidelines
⚫There is no RCT data  to support Anti-seizure 
prophylaxis use in sICH.
Ref: Stroke 2016;47:2666-72
Antiseizure prophylaxis in AIS
⚫Anti-seizure prophylaxis is not 
recommended in AIS as per 2018 ASA/AHA 
guidelines.
Ref: Stroke. 2018;49:e46–e99. 
Summary:  Anti-seizure prophylaxis
Neurosurgical Category Antiseizure Prophylaxis 
indication
TBI Yes




A Patient with Severe TBI
Protocol for patient with severe Traumatic 
Brain injury with GCS 3 with emergency 
surgery to evacuate extradural hematoma. 
Let us assume that patient is an young 
adult otherwise healthy.
Anesthetic management 
Management of severe head injury
⚫Work along with surgeon,  consider that quick 
surgery is important.
⚫Preoxygenate
⚫Discontinue clevidipine/nicardipine prior to 
induction
⚫Circulate NIBP every 1-2 min
⚫ 1 mg hydromorphone
Management of severe TBI
⚫Start phenylephrine at 0.3 mcg/kg/min
⚫Propofol 200 mg along with 80-160 mcg 
phenylephrine
⚫Goal is not to drop the BP below 110 mm Hg(as per 
BTF guidelines)
⚫CPP of  60-70 is the target(MAP 85-95 mm Hg)( as 
per BTF guidelines.
Management of severe TBI
⚫Rapid sequence induction if the patient at high risk 
of aspiration
⚫Administer defasciculating dose of Rocuronium 
before succinylcholine
⚫Use Rocuronium if the patient is not at risk of 
aspiration
⚫Gently hyperventilate the patient with low peak 
airway pressures for 3 min.
⚫Administer 1 mcg/kg of remifentanil and repeat it if 
needed as per the heart rate
⚫Quick gentle intubation in single attempt.
Management of severe head injury
⚫Use TIVA with propofol/remifentanil infusion
⚫Avoid volatile anesthetic until dura is opened(Ref 
Miller’s 9th edition, 2020)
⚫Secure the endotracheal tube well
⚫Allow the surgeon to turn the bed to 90 or 180 
degrees
⚫Administer antibiotics.
Management of severe head injury
⚫Large bore IV
⚫Arterial line
⚫Do and ABG: Figure out PaCO2-end tidal CO2 
difference and target end-tidal CO2
⚫Manage ventilation as per this end tidal CO2 target
⚫Do frequent ABG to figure out target CO2 based on 
above difference
⚫Maintain CPP 60-70 mmHg as per BTF guidelines.
Management of severe head injury
⚫Administer mannitol 1gm/kg over 15-20 min
⚫Administer Keppra 1 Gm IV over 1 hour.
⚫Post procedure transfer the patient to ICU, well 
sedated and with close monitoring of vital signs
How to reduce the ICP quickly when 
the dura is opened and bulging
⚫Discontinue volatile anesthetic agents
⚫Administer a bolus of propofol with phenylephrine
⚫Start TIVA as your primary anesthetic.
⚫Temporarily hyperventilate to 30-35 min until the 
problem settles and then maintain normocarbia.
Neuromonitoring: EEG, 
Evoked potential monitoring
Volatile anesthetic agents sensitivity
VEP> MEP> SSEP> BAEP
Anesthetic agent  and evoked potentials
Agent Amplitude Latency
Etomidate Increases increases
Ketamine Increases No change
Nitrous oxide Decreases No change
EEG
⚫Surgical anesthesia: Delta waves
⚫Opiates maximum effects: Delta waves
⚫EEG monitoring during neuroanesthesia: Target 
delta waves
⚫Dexmedetomidine max effect: alpha waves
⚫Avoid high dose of propofol infusion, use 
remifentanil and dexmedetomidine
MEP
⚫Try to avoid volatile anesthetic agents
⚫If you are using dexmedetomidine limit 
the infusion rate at 0.5mg/kg/hour
Ischemia monitoring on evoked 
potentials
⚫Decrease in amplitude and increase in latency
⚫Loss of evoked potentials
VAE updates
Updates on Venous air embolism(VAE)
A single center  report:   Mayo clinic report of extreme 
air embolism in sitting position from 2010-2013.
8 cases(6 suboccipital craniotomies, 2 DBS cases
Multiorifice CVP, TEE , Doppler used.
Cases were associated with hypotension and decrease in 
end-tidal Co2
Reference: 
Abcejo AS, Pasternak JJ, Perkins WJ. Urgent Repositioning After Venous 
Air Embolism During Intracranial Surgery in the Seated Position: A Case 
Series. J Neurosurg Anesthesiol 2019; 31:413‐421.
VAE updates
Recommendation:  1. Emergency position change to 
supine 
2.Air aspiration through CVP; not successful  in this 
case series.
3. Monitoring for embolism is indicated. Placement of 
CVP line to aspirate air is not indicated.
References:
1. Abcejo AS, Pasternak JJ, Perkins WJ. Urgent Repositioning After 
Venous Air Embolism During Intracranial Surgery in the Seated 
Position: A Case Series. J Neurosurg Anesthesiol. 2019;31:413‐421




tPA really necessary in AIS? Is it a 
placebo!!
AIS: EVT vs EVT with tPA(combination therapy)
⚫Multicenter RCT 41 tertiary academic centers(n=656)
⚫Outcome measures: Reperfusion:before 
thrombectomy (2.4% vs 7.9%) 
⚫Successful reperfusion after thrombectomy: 79.4% vs 
84.5%
⚫Mortality 17.7% vs 18.8% at 90 days
⚫Conclusion: Endovascular thrombectomy alone is non-
inferior to with regard to functional outcome at 90 days.
Ref: N Engl J Med 2020; 382:1981-1993
AIS: EVT vs EVT with tPA(combination therapy)







Mortality at 90 days 17.7 18.8
EVT 6-24 hours: DAWN trial
n=206 ( 107 thrombectomy group, 99 control group)
(multicenter)
Outcome measure: 
1. Functional independence( mRS 0-2) was better with 
thrombectomy group compared to standard of care 
(49% vs 13%)
2. 90  day mortality did not differ between the two 
groups(19% vs 18%)
Ref: N Engl J Med 2018; 378:11-21
EVT 6-24 hours: Diffuse 3 trial
Multicenter US trial (38 centers) was terminated after 
recruiting 182 patients(90 EVT group, 90 medical 
therapy group)
Outcome measures
● Functional outcome better with thrombectomy 
compared to medical therapy (45% Vs 17%)
● Mortality rate at 90 days was lower with 
thrombectomy group compared to medical therapy 
group(14% vs 26%)
Ref: N Engl J Med 2018; 378:708-718
GA Vs MAC for EVT: Does 
it matter in 2020?
GA vs MAC for EVT: Data from 
observational/retrospective studies
Observational trials  and retrospective analysis reported 
better outcome with MAC.
Limitations: 
1. GA patients had worst underlying neurological 
status
2. Time to intervention was slower in GA group
3. BP was lower in GA group.
Ref: 
1.Am J Neurol 2019; 40-10011-5
2. Stroke 2015; 46:1257–1262
3. Am J Neuroradiol 2015; 36:525–529
GA vs MAC: Single center RCT’s
RCT Year reported Country n
SIESTA(1) 2016 Germany 150
AnStroke (2) 2017 Sweden 90
Goliath(3) 2018 Denmark 128
1. .JAMA 2016; 316:1986-96
2. Stroke 2017; 48:1601-7
3. JAMA Neurol 2018; 75:470-77
RCT MAC GA






GOLIATH propofol/Fentanyl Propofol /alfentanil/ Succinylcholine for 
induction
Propofol/remifentanil for maintenance 
GA vs MAC: RCT data
A meta-analysis(reported in 2019) of three RCTs comparing GA vs MAC
SIESTA(Germany), ANSTROKE(Sweden),  and GOLIATH(Denmark) 
n= 365, large vessel occlusion in anterior circulation
Outcome measures: GA group had favourable functional independence 
at 90 days.
Ref:
1. Front Neurol. 2019;10:1131
2. J Am Heart Assoc 2019; 8e011754
GA  vs MAC 
⚫n= 88 
⚫TIVA was used in both groups
⚫Conversion of sedation to GA: 9.52%
⚫ (SIESTA 14.3%, Goliath 15.6%)
⚫No difference in functional outcome or mortality 
rate at 90 days
Ref: Frontiers in Neurology: doi.org/10.3389/fneuro2020.00170
GA vs MAC for EVT: What we should in 2020?
Choice of the technique depends on patients baseline 
neurological status as per 2019 ASA of AHA statement. 
Stroke 2019; 50:e344-e418
GA vs MAC for EVT in AIS: Ongoing trials
1. AMETIS trial (Anesthesia Management in Endovascular 
Therapy for Acute Ischemic Stroke (n=270)
1. SEGA (SEdation Versus General Anesthesia for 
Endovascular Therapy in Acute Ischemic Stroke)(n=270)
Ref: 




Elective DC for TBI
⚫Decompressive Craniectomy (DECRA, n= 155)( Ref 1)
⚫Craniectomy for Uncontrollable Elevation of ICP 
(RESCUEicp  n= )( Ref 2)
Results;No benefit for early elective DC 
Ref 1: N Engl J Med 2011; 364:1493-1502
Ref 2: N Engl J Med 2016; 375:1119-1130
DECRA: Elective DC for TBI
Diffuse TBI
GCS 3-8
Standard Rx vs Standard Rx + DC
n= 155, multicenter, 15 centers
DC: Bifrontotemporal DC within 72 hours of 
randomization with a target ICP of 20 mm Hg ( 15 min 
period in hour period )
Results: DC group had worse neurological outcome and 
death rate at 6 months.
Ref: N Engl J Med 2011; 364:1493-1502
Rescue ICP trial: DC for TBI
Standard Rx Vs Standard rx+DC
n= 408, multicenter RCT
Target  refractory  persistent ICP 25 mmHg for 1-12 
hours
Results: 
Lower mortality, but higher vegetative state/ severe 
disability  in survivors in DC group.
Good recovery and moderate disability was similar in 
both group.
Ref: N Engl J Med 2016; 375:1119-1130
Elective DC for TBI ?
Based on DECRA and Rescueicp trial: Elective 
DC is not indicated in severe diffuse TBI
Elective DC for AIS
⚫The Hemicraniectomy After Middle Cerebral Artery 
Infarction With Life-threatening Edema Trial 
[HAMLET]): A Multicentre, Open, Randomised Trial 
⚫n-64, 32 DC and 32 best medical treatment
⚫MCA hemispheric infarction were included in the 
trial
⚫DC was done within 4 days
Assessment: mRankin score at 1 year
Results; Benefit of DC if done within 48 hours
DHC for MCA hemispheric stroke
⚫ A meta-analysis reported in 2020
⚫9 RCTs including HEMLET, DECIMAL and 
DESTINY trials
⚫N= 425, 210=DHC, 215= best medical management
⚫Results: DHC performed with 48 hours was 
associated with better survival rate and 
functional outcome.
Ref: Bioscience Reports 2020;  40 BSR 20191448
PMID 31854446
Deep Brain stimulation(DBS)
⚫GABAergic drugs midazolam should be avoided.
⚫Long acting opiates should be avoided.
⚫Dexmedetomidine 1 mcg/kg bolus followed by 0.2-
0,7 mcg/kg/hr
⚫Remifentanil 0.01-0.05 mcg/kg/min
⚫Propofol infusion, avoid bolus
⚫Stop everything for assessment.
⚫Keep  systolic BP 120-140 mm Hg for electrode 
implantation and MAP above 70 mmHg. 
⚫Limit the fluids
Updates on Intracranial 
aneurysms
Clipping of aneurysms
During application of an temporary clip
⚫Maintain MAP
⚫Administering additional propofol is a common practice, 
but benefit of such practice is not proven(Ref 1)
Ref 1: Anesthesiology. 2010; 112:86-101
Optimum duration of temporary 
clipping
Common practice:
Optimum duration: 10 min for MCA and  upto 20 min in 
other locations.
Optimum duration of temporary clipping;
What is new?
A prospective observational trial(n=24)(13 ruptured and 
11 unruptured MCA aneurysms)
MEP monitoring
Safe duration was 2.4 min with 95% confidence interval 
based on MEP changes








⚫ Prolonged effect in AV blocks, digoxin and 
verapamil 
⚫Contraindications: CAD, Severe asthma, AV block
Ref:
1.Stroke Vasc Neurol. 2017; 2:204–9
2. J Neurosurg 2018; 129:3
3. Stroke 2012; 43; Supp 1
Endovascular techniques for the 
treatment of aneurysms
⚫Endovascular coiling
⚫Endovascular stent assisted coiling for larger 
aneurysms
⚫Endovascular flow diversion techniques
Endovascular Flow diversion: 
Updates
Traditional endoluminal flow diversion: Deploys the 
diverter within the lumen of the parent vessel at the neck of 
the aneurysm (PED, Silk, Surpass,FRED)
Intrasaccular Flow diversion: Deployment of self expanding 
new diverters within the aneurysm.(WEB, Medina, LUNA)
Ref: Neurosurgical Focus 2017; 42: 1
PED illustration from AJNR Am J Neuroradiol : 2019 
www.ajnr.org




In order to achieve complete occlusion of the aneurysm
ideal flow diverter should have
1. High metal content
2. Decreased porosity
3. Optimum porosity in order to prevent attenuation 
and occlusion of pores
FRED dual layer flow diverters 
The device consists of a braided self-expandable 
closed-cell dual-layer stent (also referred to a “stent 





⚫ 375 posterior circulation  unruptured aneurysms in 369 patients.
⚫ PED was used in 285 (77.2%) and FRED in 84 (22.8%) procedures
⚫ Limitations: PED was used in larger and fusiform  aneurysms.
⚫ In Order to eliminate propensity score matching was used to 
compare 33 FRED and 33 PED aneurysms
Results: Occlusion rate and complication rate were similar in both 
groups.
Functional outcome was better in FRED group.
Ref: J Intervent Surg 2020http://dx.doi.org/10.1136/neurintsurg-2020-016055
Coiling vs Flow diversion
Endovascular coiling vs flow diversion: a meta-analysis 11 
studies (10 retrospective, 1 prospective)
n=611 coiling, 576 Flow diversion
Results:  Flow diverters, compared to coiling  had
⚫ Higher rate of aneurysm occlusion(immediate and delayed)
⚫ No difference in overall intraoperative complication rate
⚫ No difference in functional outcome score measured on 
mRankin
⚫ Flow diverts reduce cost and time of fluoroscopy per case
Ref: World Neurosurgery, 2019;  128: 464-72
Problems with endoluminal 
flow diverters
⚫Dual Antiplatelet therapy is needed to 
prevent stent thrombosis.
⚫Clopidogrel typically started 5 days prior 
to intervention
⚫Aspirin 325 mg  and Plavix continued 
post procedure until 6 months.




⚫Hemorrhagic transformation of AIS.
⚫Stent migration
Endoluminal flow diverters
A prospective observational trial from France with PED and 
Silk flow diverters recently reported in 2019 at 12 months 
(n=398 patients, 477 aneurysms): Diversion study. (Oct 
2012- Oct 2014)
⚫ Satisfactory occlusion rate 80%
⚫Major complication rate 5.6%
⚫Mortality rate as 1.2%
Ref: Stroke. 2019;50:3471–3480
Flow diverters for intracranial aneurysm
A meta-analysis of 6o studies( 3125) reported in 2017,
⚫The neurological complication rate was 4.5%.
⚫Mortality rate was 2.8%
⚫No difference between PED and Silk flow diverters
⚫Complication rate was higher in ruptured aneurysms 
in this analysis.(Odds ratio of  2.3 with 95% CI, 1.2-
4.2)
Ref: Neurosurgical Focus 2017; 42:6
Intrasaccular WEB Flow diverter:
Illustration from Stroke and Vascular Neurology 2016;1:e000027
Endovascular Flow diversion: Updates
Advantages of intrasaccular flow diverters over 
intra luminal diveters
⚫ Dual antiplatelet therapy not required
⚫ Less risk hemorrhagic transformation of AIS from 
platelet therapy
⚫Less chance of stent thrombosis of flow diverter
⚫Less chance Flow diverter migration
Ref: Neurosurgical Focus 2017; 42: 1
DCI after aSAH: 
Pathophysiology
EBI: Loss of BBB, autoregulation
Vasospasm
CSD( Cortical spreading depression)
DIC as part of SOFA( old terminology: (SIRS)
References:
1.  J Clin Neurophysiol. 2016; 33 :196–202
2. Cereb Blood Flow Metab 2017; 37:1595-1625
DCI management
IAD (Intra-arterial vasodilator) therapy with 
vasodilators(milrinone etc) is beneficial as per a 
meta-analysis(n= 1561, 56 studies ) 
Immediate angiographic reversal(89%), improved 
outcome 66% and mortality 5%.
Ref: J Neurointerv Surg 2018;10:380-387.
DCI management
HHH part of the history now. 
Prophylactic Induced  was used until recently.
DCI management
RCT( n=240) was prematurely terminated after 
recruiting 42 patients : after observing no benefit.
Ref 1: Stroke 2018;49:76–83
DCI  management:current concept
⚫Prophylactic induced hypertension: Not indicated
⚫Prophylactic oral nimodipine is indicated








A Large vascular tumor: 
A Double edged sword!!
Goal: 1. Prevention of coagulopathy with blood 




4. Do not lower BP to prevent bleeding as in trauma 
DCR principle  
DCR in Neurosurgery
⚫Avoid large  amount of crystalloids
⚫Use  blood/blood products
⚫Consider TXA
⚫Maintain CPP.
Elective surgery after AIS: 
How long we have to wait?
Elective surgery after AIS: How 
long we have to wait?
National registry analysis from Denmark  2005-2011, 
reported in 2014
n= 7137( with AIS)
n= 474046 ( without AIS)
Risk of AIS and MI was 54.4% with  prior AIS and 4.1% 
without prior AIS if the surgery was done within three 
months.
Ref: JAMA 2014;312:269-277
Elective surgery after AIS: How long we 
have to wait?
All elective surgery should be postponed for 9 months 
after Stroke as per
1. American College of Surgeons 2018 guidelines( Ref 1)
1. 2020 Guidelines From the Society for Neuroscience 
in Anesthesiology and Critical Care ( Ref 2)
Ref:
1. J Am Coll Surg 2018; 227:521-36 
2. J Neurosurg Anesthesiol 2020; 32: 210-26
